Wave Life Sciences Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +72.4% | +0.0% | +0.0% | +0.0% | +147.9% | -15.2% | +243.1% | -7.9% | -19.4% | -16.4% | +152.1% | -61.6% | -18.1% | +73.4% | -27.3% | +14.0% | +173.6% | +0.0% | -70.6% | +1,212.1% | -95.2% | -0.8% | -78.6% | -24.0% | +334.7% | +943.5% | +71.0% | +122.6% | -41.0% | -56.8% | +57.1% | -139.0% | – | -89.0% | -5.2% | -12.5% | +126.7% | +121.8% | -94.1% | – | |
| – | +2.3% | +5.3% | +29.6% | +5.2% | +26.2% | +15.1% | +11.5% | +1.0% | +21.1% | +0.8% | +3.7% | +7.2% | +10.2% | -16.2% | -23.5% | -10.2% | +6.2% | +11.2% | -5.3% | -1.7% | -17.1% | +6.6% | +8.2% | -7.3% | -91.0% | +1,141.6% | +7.5% | -5.0% | -93.1% | -0.2% | -0.2% | -0.6% | +2,946.0% | -96.7% | +1.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -549.6% | – | – | – | – | – | – | – | +52.9% | -53.3% | +57.1% | -139.0% | – | -91.6% | -7.2% | +17.0% | +96.9% | +155.3% | -94.1% | – | |
| – | +2.3% | +5.3% | +29.6% | +5.2% | +26.2% | +15.1% | +11.5% | +1.0% | +21.1% | +0.8% | +3.7% | +7.2% | +10.2% | -16.2% | -23.5% | -10.2% | +6.2% | +11.2% | -5.3% | -1.7% | -17.1% | +6.6% | +8.2% | -7.3% | +12.7% | -0.3% | +7.5% | -5.0% | +7.7% | -1.8% | +20.8% | +2.0% | +8.4% | -9.0% | +7.0% | +5.5% | +15.1% | -10.2% | +8.1% | – | |
| – | +31.6% | +12.8% | +14.0% | +13.6% | -9.0% | +16.2% | +11.3% | +10.6% | +29.5% | -14.5% | +6.8% | +7.6% | +10.2% | -5.9% | -21.5% | -6.0% | +1.3% | +3.7% | +8.8% | +18.0% | -6.4% | +2.1% | +3.5% | -9.3% | +18.2% | -10.8% | +0.2% | +7.0% | +4.1% | -0.8% | +5.5% | +5.2% | +7.3% | +13.8% | -2.0% | +0.5% | +15.5% | +5.8% | +12.1% | – | |
| – | +8.8% | +7.4% | +25.2% | +7.4% | +16.6% | +15.3% | +11.4% | +3.1% | +23.0% | -2.9% | +4.4% | +7.3% | -75.8% | -5.9% | -21.5% | -6.0% | +1.3% | +3.7% | +8.8% | +18.0% | -6.4% | +2.1% | +3.5% | -9.3% | +285.9% | -72.7% | +0.2% | +7.0% | +247.0% | +3.2% | +16.4% | +2.8% | +8.1% | -6.5% | +4.3% | +7.9% | +11.7% | -2.7% | +9.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -520.4% | – | – | – | – | -316.9% | – | – | – | – | – | – | |
| – | +185.6% | -99.1% | -66.7% | +0.0% | +500.0% | +16.7% | -42.9% | +25.0% | +340.0% | +4,536.4% | +52.2% | -21.8% | -39.0% | +0.0% | -99.7% | +750.0% | -5.9% | – | – | – | – | – | +210.0% | -87.9% | +1,502.9% | +71.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -305.0% | – | – | – | – | -260.3% | – | – | – | – | – | – | |
| – | -50.8% | +589.4% | -98.6% | -2,411.1% | – | – | -645.3% | – | – | – | – | – | – | – | – | – | – | -101.3% | – | – | – | -237.3% | – | – | +548.6% | +0.0% | -771.5% | – | +1,000.9% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -324.2% | – | – | – | – | -260.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -254.2% | – | – | – | – | -242.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.